Syngene delivers decent results on the back of growth in discovery services & dedicated centers, revenue visibility looks strong with the renewal of contracts with Amgen for 5 years | Q3FY22 Result Analysis
Syngene delivers decent results on the back of growth in discovery services & dedicated centers, revenue visibility looks strong with the renewal of contracts with Amgen for 5 years | Q3FY22 Result Analysis
Syngene delivers decent results on the back of growth in discovery services & dedicated centers, revenue visibility looks strong with the renewal of contracts with Amgen for 5 years | Q3FY22 Result Analysis